UCAZO Trademark

Trademark Overview

On Monday, June 27, 2011, a trademark application was filed for UCAZO with the United States Patent and Trademark Office. The USPTO has given the UCAZO trademark a serial number of 85356963. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 23, 2015. This trademark is owned by Salix Pharmaceuticals, Inc.. The UCAZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of and treatment of gastrointestinal diseases and disorders with prescription pharmaceutical preparations containing balsalazide or balsalazide disodium
ucazo

General Information

Serial Number85356963
Word MarkUCAZO
Filing DateMonday, June 27, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 23, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention of and treatment of gastrointestinal diseases and disorders with prescription pharmaceutical preparations containing balsalazide or balsalazide disodium

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 1, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSalix Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27615
Party NameSalix Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Trademark Events

Event DateEvent Description
Monday, February 23, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 23, 2015ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 31, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 30, 2014EXTENSION 5 GRANTED
Thursday, July 17, 2014EXTENSION 5 FILED
Thursday, July 17, 2014TEAS EXTENSION RECEIVED
Wednesday, January 29, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 28, 2014EXTENSION 4 GRANTED
Thursday, January 9, 2014EXTENSION 4 FILED
Thursday, January 9, 2014TEAS EXTENSION RECEIVED
Thursday, August 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2013EXTENSION 3 GRANTED
Monday, July 15, 2013EXTENSION 3 FILED
Friday, August 9, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 15, 2013TEAS EXTENSION RECEIVED
Wednesday, January 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 22, 2013EXTENSION 2 GRANTED
Wednesday, January 16, 2013EXTENSION 2 FILED
Wednesday, January 16, 2013TEAS EXTENSION RECEIVED
Tuesday, July 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 30, 2012EXTENSION 1 GRANTED
Tuesday, July 10, 2012EXTENSION 1 FILED
Friday, July 27, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 10, 2012TEAS EXTENSION RECEIVED
Tuesday, January 17, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 14, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2011ASSIGNED TO EXAMINER
Friday, July 1, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 30, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

ucazo balsalazide pharmaceutical preparations containing disodium prescription diseases prevention treatment gastrointestinal